Angioprotein-like 3 and atheroma progression in statin-treated type 2 diabetic patients with coronary artery disease: the pre-specified analysis from the OPTIMAL randomized controlled trial.
30 August 2024 (08:00 - 17:30)
Organised by: 

About the speaker

Kashiwa Kosei General Hospital, Kashiwa (Japan)
6 More presentations in this session
Doctor S. Datla (Cleveland, US)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
